In the state prison we have recently begun to provide MOUD to individuals upon intake to the carceral setting. Individuals eligible to receive MOUD are those with a diagnosed SUD who have been enrolled in a validated community treatment program. At this point we are only continuing individuals on MOUD, and not initiating persons upon intake. Buprenorphine is the only medication offered.
Yes, this is an ongoing effort supported by legislation, and as time goes on, we are actively working to enhance and expand the program.
One of the biggest barriers is coordination of programs and staffing constraints. The treatment for incarcerated individuals is housed within the Department of Health and Human Services but is located at the Department of Corrections. Identifying the needed communication channels, developing protocols to help span the two entities, and gain leadership buy-in.
Not at present. We are working with the probation/parole and reentry teams to build a network of community treatment centers for connection upon release.
We have been connecting with surrounding states with similar populations and political structures to model and connect on lessons learned. Research studies and implementation guidance are helpful.
Most of our jails across UT state that they offer MOUD, but often it is only Vivitrol. Currently MOUD is only being offered in one of our state prisons.
There is significant room for improvement in the treatment provided to incarcerated persons. When comparing access to treatment between incarcerated populations and nonincarcerated populations, there continue to be disparities for incarcerated persons.